Speaker

Juan Pablo Arab, MD, FRCPC

Virginia Commonwealth University
Director of Alcohol Sciences, Stravitz-Sanyal Institute of Liver Disease and Met
Juan Pablo Arab, MD, FRCPC

Biography

Dr. Arab is an Associate Professor of Medicine at the Division of Gastroenterology, Hepatology, and Nutrition of Virginia Commonwealth University School of Medicine. He serves as the Inaugural Director of Alcohol Sciences at the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health. Dr. Arab trained as Gastroenterologist and Transplant Hepatologist specialist at the Catholic University of Chile and at the Mayo Clinic, Rochester, MN. Dr. Arab's research in alcohol-associated liver disease (ALD) has truly refined the clinical hepatology practice and our understanding of this common disease. Additionally, he is leading international collaborations aiming to study ALD and metabolic dysfunction-associated steatotic liver disease (MASLD) through multiple consortia. Dr. Arab is an Associate Editor for Hepatology (flagship AASLD journal). He is currently the Chair of the Special Interest Group on ALD of the AASLD. He has published more than 250 peer-reviewed papers, co-authored several book chapters and authored multiple clinical practice guidelines on ALD, MASLD and hepatorenal syndrome.

Sessions

2:00 PM - 3:30 PM
Nov 07 2025
Washington, D.C.

Transforming Lives in Alcohol-Associated Liver Disease: Early Detection, Equitable Treatment, and Inclusive Research Strategies 

Stephen Silva-Brave, MSW, Presenter
Erin Cleveland, MD, Presenter
Juan Pablo Arab, MD, FRCPC, Presenter
Lamia Y. Haque, MD, MPH, Presenter
ALD
Patient Program
4:00 PM - 5:30 PM
Nov 07 2025
Washington, D.C.

Obesity and Addiction Medicine in Liver Disease: Translating Science Into Practice, Part 2—Interventions and Long-Term Management (Ticketed)

Reem Z Sharaiha, MD MSc, Presenter
Shira Zelber-Sagi, PhD, Presenter
Brittany Bromfield, MD, Presenter
ALD
MASLD
8:00 AM - 9:30 AM
Nov 08 2025
Washington, D.C.

Steatotic Liver Disease: What You Need to Know, Part 1. Steatotic Liver Disease at the Crossroads—Bridging Alcohol-Associated Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the Era of Multimorbidity

Veeral Ajmera, MD, Presenter
Miriam B. Vos, MD, MSPH, FAASLD, Presenter
Brian P Lee, MD, Presenter
Gerald Scott Winder, MD MSc FACLP, Presenter
ALD
MASLD
2:00 PM - 3:30 PM
Nov 08 2025
Washington, D.C.

Steatotic Liver Disease: What You Need to Know, Part 2. Dual Threats—Advancing Research and Care in Steatotic Liver Disease

Shira Zelber-Sagi, PhD, Presenter
Naim Alkhouri, MD, FAASLD, Presenter
Alina M. Allen, MD, Presenter
Gene Im, MD, FAASLD, Presenter
ALD
MASLD
2:00 PM - 3:30 PM
Nov 09 2025
Washington, D.C.

Academic Advancement, Promotion, and Tenure for Under-Represented Groups in Hepatology

Gyongyi Szabo, MD, PhD, FAASLD, Presenter
HoChong Gilles, DNP, FNP-C , AF-AASLD, Presenter
Andrea Reid, MD, MPH, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Basic Science
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Hepatitis
Hepatology Associates
Liver Cancer
MASLD
Patient Program
Pediatrics
Trainee
Transplant